Approval · Notice of Compliance 3493 · 2003
SYNERCID: Notice of Compliance 3493
Issued October 21, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3493
- Date
- October 21, 2003
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph - revised dosage recommendations for populations at risk; interaction study with rifampin
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNERCID | Not yet assigned | — |
Medicinal ingredients
- QUINUPRISTIN 150 MG per VIAL
- DALFOPRISTIN 350 MG per VIAL